| Product |
CAS |
Molecular formula |
More |
| Oxazole, 4-bromo-5-ethoxy-2-ethyl-(9ci) |
284040-96-6 |
C7H10BrNO2 |
More |
| Oxazole, 4-bromo-5-ethoxy-2-methyl-(9ci) |
284040-93-3 |
C6H8BrNO2 |
More |
| Piperazine, 1-[(5-methyl-3-pyridinyl)methyl]-(9ci) |
182354-90-1 |
C11H17N3 |
More |
| Piperazine, 1-[(6,12-dihydro-4-methoxy-6,12-dioxoindolo[2,1-b]quinazol |
169038-55-5 |
C21H20N4O5S |
More |
| Oxazole, 4-butyl-2-ethyl-4,5-dihydro-5-methyl-5-(2-propenyl)-(9ci) |
205745-13-7 |
C13H23NO |
More |
| Piperazine, 1-[(6-ethoxy-4-hydroxy-3-quinolinyl)carbonyl]-(9ci) |
604773-10-6 |
C16H19N3O3 |
More |
| Oxazole, 4-cyclopentyl-4,5-dihydro-2-methyl-, (4r)-(9ci) |
223473-38-9 |
C9H15NO |
More |
| Piperazine, 1-[(6-ethoxy-4-hydroxy-3-quinolinyl)carbonyl]-4-ethyl-(9ci |
604773-05-9 |
C18H23N3O3 |
More |
| Oxazole, 4-ethoxy-5-hexyl-4,5-dihydro-5-methyl-(9ci) |
128101-14-4 |
C12H23NO2 |
More |
| Piperazine, 1-[(6-ethoxy-4-hydroxy-3-quinolinyl)carbonyl]-4-methyl-(9c |
604772-99-8 |
C17H21N3O3 |
More |
| Oxazole, 4-ethyl-4,5-dihydro-2-(2-phenylethenyl)-(9ci) |
246240-63-1 |
C13H15NO |
More |
| Piperazine, 1-[(8-ethyl-4-hydroxy-3-quinolinyl)carbonyl]-4-methyl-(9ci |
604773-72-0 |
C17H21N3O2 |
More |
| Oxazole, 4-ethyl-5-methyl-2-(1-methylethyl)-(9ci) |
84027-96-3 |
C9H15NO |
More |
| Piperazine, 1-[(8-fluoro-4-hydroxy-3-quinolinyl)carbonyl]-(9ci) |
604773-25-3 |
C14H14FN3O2 |
More |
| Oxazole, 5-(1-diazoethyl)-2,4-dimethyl-(9ci) |
72591-39-0 |
C7H9N3O |
More |
| Piperazine, 1-[(aminooxy)acetyl]-4-methyl-(9ci) |
112257-39-3 |
C7H15N3O2 |
More |
| Oxazole, 5-(2-thiazolyl)- |
681135-47-7 |
C6H4N2OS |
More |
| Piperazine, 1-[(cyclopropylamino)acetyl]-4-(4-methoxyphenyl)-(9ci) |
606096-38-2 |
C16H23N3O2 |
More |
| Piperazine, 1-[(diethylmethylsilyl)methyl]-4-methyl-(8ci) |
21659-88-1 |
C11H26N2Si |
More |
| Oxazole, 5-(bromomethylene)-4,5-dihydro-2,4,4-trimethyl-(9ci) |
785713-62-4 |
C7H10BrNO |
More |
